GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » EirGenix Inc (ROCO:6589) » Definitions » Sale Of Investment

EirGenix (ROCO:6589) Sale Of Investment : NT$31 Mil (TTM As of Dec. 2024)


View and export this data going back to 2016. Start your Free Trial

What is EirGenix Sale Of Investment?

EirGenix's sale of investment for the three months ended in Dec. 2024 was NT$0 Mil. It means EirGenix gained NT$0 Mil from selling investments. EirGenix's sale of investment for the trailing twelve months (TTM) ended in Dec. 2024 was NT$31 Mil.

Compared with last quarter (NT$0 Mil in Sep. 2024 ), EirGenix gained the same money from selling investments in Dec. 2024 (NT$0 Mil).


EirGenix Sale Of Investment Historical Data

The historical data trend for EirGenix's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EirGenix Sale Of Investment Chart

EirGenix Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.26 3.27 1,663.97 4,200.40 1,531.57

EirGenix Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 31.27 - - -

EirGenix Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$31 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


EirGenix Sale Of Investment Related Terms

Thank you for viewing the detailed overview of EirGenix's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


EirGenix Business Description

Traded in Other Exchanges
N/A
Address
No. 101, Lane 169, Kangning Street, Xizhi District, New Taipei, TWN, 22180
EirGenix Inc is engaged in biosimilar and new drug research and development as well as biopharmaceutical contract development and manufacturing services, including cell line construction platforms, process development platforms, analytical science and protein characterisation, as well as PIC/S facilities to provide clinical trial drug production. Its services include Cell Line Development, Process Development, Analytical Science and Quality Control, cGMP manufacturing-mammalian system, cGMP manufacturing-microbial system, and Antibody Drug Conjugate.

EirGenix Headlines

No Headlines